BMA, Avalere Research Illustrates MA Outperformance on Multiple Care Measures

A new study comparing quality outcomes for Medicare Advantage enrollees vs. traditional fee-for-service (FFS) Medicare beneficiaries found that high-need, high-cost populations enrolled in MA had better care experiences for most clinical quality measures and had significantly higher rates of preventive screenings for several measures. While MA didn’t outperform FFS across all measures, the findings suggest that care management in MA results in higher quality of care for this vulnerable population, observed the study, which was conducted by Avalere Health on behalf of Better Medicare Alliance. Using a “matched” study population of 1,262,180 for both FFS and MA, the research focused its findings on three groups in particular: individuals who are under 65 and enrolled in Medicare due to a disability, the frail elderly, and those with major chronic complex conditions.

© 2021 MMIT

Lauren Flynn Kelly Managing Editor, Radar on Medicare Advantage

Lauren has been covering health business issues, including drug benefits and specialty pharmacy, for more than a decade. She served as editor of Drug Benefit News (the predecessor to Radar on Drug Benefits) from 2004 to 2005 and again from 2011 to 2016, and now manages Radar on Medicare Advantage. Lauren graduated from Vassar College with a B.A. in English.

Related Posts

https://www.mmitnetwork.com/wp-content/uploads/2021/11/WordPress-Featured_AdobeStock_274078056.jpg
November 18

Medicare Advantage Insurers Step Up SNP Offerings for 2022, Particularly for Duals

READ MORE
https://www.mmitnetwork.com/wp-content/uploads/2021/09/MCO-Stock-Performance-August-2021.jpg
November 18

Given COVID Surge, Humana Deviates From Peers With Lower Guidance

READ MORE
https://www.mmitnetwork.com/wp-content/uploads/2021/09/WordPress-Featured-Image-radar-on-medicare-advantage-MedPAC-Reforms-to-Part-D-LIS-Could-Produce-Savings.jpg
November 18

Clover Health Struggles to Contain Medical Costs for MA Members

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today